Paper Details

  1. Home
  2. Paper Details

Efficacy of four antiviral agents in the treatment of uncomplicated herpetic keratitis.

Author: DasG K, KhokharS, PandaA, RaoV

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

BVDU has a more pronounced therapeutic effect than idoxuridine, trifluorothymidine and acyclovir in uncomplicated epithelial herpetic disease of recent onset that has not previously been treated.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To evaluate the efficacy of four antiviral agents--1% idoxuridine ointment (group 1), 2% trifluorothymidine ointment (group 2), 3% acyclovir ointment (group 3) and 1% bromovinyldeoxyuridine (BVDU) ointment (group 4)--in herpes simplex keratitis. DESIGN: Randomized double-blinded clinical...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/8529160

データ提供：米国国立医学図書館（NLM）

Antiviral Treatments for Herpetic Keratitis: A Comparative Study

Herpetic keratitis, a viral infection of the cornea, can cause significant vision loss. Antiviral drugs are the mainstay of treatment for this condition. This study compared the efficacy of four antiviral agents - idoxuridine ointment, trifluorothymidine ointment, acyclovir ointment, and bromovinyldeoxyuridine (BVDU) ointment - in treating uncomplicated herpetic keratitis. Researchers conducted a randomized, double-blinded clinical trial to determine which antiviral agent was most effective in treating this infection. They evaluated the cure rate, healing time, and incidence of side effects associated with each treatment.

BVDU: A Superior Antiviral for Uncomplicated Herpetic Keratitis

The study found that BVDU was significantly more effective than idoxuridine, trifluorothymidine, and acyclovir in treating uncomplicated herpetic keratitis. BVDU had a higher cure rate, shorter healing time, and fewer side effects. These findings suggest that BVDU may be the preferred treatment option for this type of infection. This research is like finding a hidden spring in a desert, a source of healing and renewal that can effectively combat a potentially debilitating infection.

Antiviral Treatments for Herpetic Keratitis: Choosing the Right Therapy

This study underscores the importance of choosing the appropriate antiviral treatment for herpetic keratitis. It's like navigating a desert landscape, where each path leads to a different outcome. By carefully selecting the optimal therapy, healthcare professionals can improve patient outcomes and minimize the risk of complications.

Dr.Camel's Conclusion

This study offers valuable insights into the efficacy of different antiviral agents for herpetic keratitis. It's like discovering a hidden oasis in a desert, where different springs offer varying degrees of healing power. The findings highlight the importance of choosing the right therapy to optimize patient outcomes and combat this potentially vision-threatening infection.

Date :
  1. Date Completed 1996-01-30
  2. Date Revised 2016-10-13
Further Info :

Pubmed ID

8529160

DOI: Digital Object Identifier

8529160

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.